Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases

Conclusion: Despite higher baseline disease burden and complexity, post-procedure HRU and clinical complications for PEDD patients were similar to non-PEDD patients. The complex baseline clinical profile may reflect selection of challenging cases for PEDD use. Future studies should validate the benefits observed with PEDD embolization in larger samples with greater statistical power.PMID:38414420 | DOI:10.1080/03007995.2024.2322057

Source: Current Medical Research and Opinion - February 28, 2024 Category: Research Authors: Keziah Cook Deepshekhar Gupta Yunjuan Liu Chris Miller-Rosales Fangzhou Wei Edward Tuttle Steven C Katz Richard Marshak Alexander Y Kim Source Type: research